Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
December 13, 2006
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener
Robert J Altenbach, Michael E Brune, Steven A Buckner, et al.
Journal of Biomolecular Screening
|
November 14, 2006
Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists
Jun Chen, Marc R Lake, Reza S Sabet, et al.
Journal of Medicinal Chemistry
|
May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor
Ramin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Journal of the American Society of Nephrology : JASN
|
August 23, 2017
Targeting Anti-TGF-<i>β</i> Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach
Steve McGaraughty, Rachel A Davis-Taber, Chang Z Zhu, et al.
British Journal of Pharmacology
|
August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892
Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization
Murali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Journal of Medicinal Chemistry
|
May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro
William A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
CNS Drug Reviews
|
June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders
Lynne E Rueter, David J Anderson, Clark A Briggs, et al.
Biochemical Pharmacology
|
May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats
Chang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S Bitner, William H Bunnelle, David J Anderson, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
December 13, 2006
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener
Robert J Altenbach, Michael E Brune, Steven A Buckner, et al.
Journal of Biomolecular Screening
|
November 14, 2006
Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists
Jun Chen, Marc R Lake, Reza S Sabet, et al.
Journal of Medicinal Chemistry
|
May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor
Ramin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Journal of the American Society of Nephrology : JASN
|
August 23, 2017
Targeting Anti-TGF-<i>β</i> Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach
Steve McGaraughty, Rachel A Davis-Taber, Chang Z Zhu, et al.
British Journal of Pharmacology
|
August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892
Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization
Murali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Journal of Medicinal Chemistry
|
May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro
William A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
CNS Drug Reviews
|
June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders
Lynne E Rueter, David J Anderson, Clark A Briggs, et al.
Biochemical Pharmacology
|
May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats
Chang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S Bitner, William H Bunnelle, David J Anderson, et al.
Page
of 9